Imat 400 mg tablet
In stock
Description
Imat 400 mg Tablet contains Imatinib 400 mg, a targeted anti-cancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It is marketed by Zydus Healthcare Ltd. and is available as a prescription medicine.
Uses
Chronic myeloid leukemia (CML)
Certain types of acute lymphoblastic leukemia (ALL)
Gastrointestinal stromal tumors (GIST)
Certain other blood and solid tumors, depending on the specific diagnosis
How it works: Imatinib blocks specific abnormal tyrosine kinase proteins that help cancer cells grow and multiply, thereby slowing or stopping the growth of these cells.
